ADAR1 Capital Management »

Fusion Pharmaceuticals shares owned by ADAR1 Capital Management

Quarter-by-quarter ownership of Fusion Pharmaceuticals (FUSN) shares owned by ADAR1 Capital Management from 13F filings

Historical chart of ADAR1 Capital Management investment in Fusion Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Fusion Pharmaceuticals held by ADAR1 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Fusion Pharmaceuticals by ADAR1 Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $3.8M 177k 21.32

More positions owned by ADAR1 Capital Management

Alnylam Pharmaceuticals (ALNY)
Ea Series Trust Alpha Arch 1-3 (BOXX)
Roivant Sciences SHS (ROIV)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Protagonist Therapeutics (PTGX)
Cytokinetics Com New (CYTK)
Keros Therapeutics (KROS)
Royalty Pharma Shs Class A (RPRX)
Bridgebio Pharma (BBIO)
Merrimack Pharmaceuticals In Com New (MACK)
Ascendis Pharma A/s Sponsored Adr (ASND)
Arbutus Biopharma (ABUS)
Avrobio Ord (AVRO)
Beigene Sponsored Adr (BGNE)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)

View all positions for ADAR1 Capital Management

Top funds holding Fusion Pharmaceuticals

Federated Investors
Perceptive Advisors
Avidity Partners Management
Deerfield Management Company
Fil
Pentwater Capital Management
Johnson & Johnson
Millennium Management
Tpg Gp A
TIG Advisors
FMR
Marshall Wace
Verition Fund Management
Qube Research & Technologies
William Blair $ Company

View all funds holding Fusion Pharmaceuticals